GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Price-to-Free-Cash-Flow

Ceapro (TSXV:CZO) Price-to-Free-Cash-Flow : N/A (As of May. 25, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Ceapro Price-to-Free-Cash-Flow?

As of today (2024-05-25), Ceapro's share price is C$0.27. Ceapro's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.06. Hence, Ceapro's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Ceapro's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Ceapro's highest Price-to-Free-Cash-Flow Ratio was 325.71. The lowest was 7.97. And the median was 15.95.

TSXV:CZO's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.69
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Ceapro's Free Cash Flow per Share for the three months ended in Dec. 2023 was C$-0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.06.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Ceapro was -173.80% per year.

During the past 13 years, Ceapro's highest 3-Year average Free Cash Flow per Share Growth Rate was 107.10% per year. The lowest was -144.80% per year. And the median was 20.60% per year.


Ceapro Price-to-Free-Cash-Flow Historical Data

The historical data trend for Ceapro's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ceapro Price-to-Free-Cash-Flow Chart

Ceapro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.56 13.47 16.94 7.38 -

Ceapro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.38 13.00 215.00 - -

Competitive Comparison of Ceapro's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Ceapro's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ceapro's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ceapro's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ceapro's Price-to-Free-Cash-Flow falls into.



Ceapro Price-to-Free-Cash-Flow Calculation

Ceapro's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.27/-0.059
=N/A

Ceapro's Share Price of today is C$0.27.
Ceapro's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Ceapro  (TSXV:CZO) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Ceapro Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ceapro's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ceapro (TSXV:CZO) Business Description

Traded in Other Exchanges
Address
7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2
Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (TSXV:CZO) Headlines

No Headlines